Free tool
Oncology stocks
We cover 5 companies grouped under the Oncology theme. The median market value in the group is $2.11M. Across the group, the median move over the past trading day is −4.87%. Price change over the past year runs from −99.2% to −47.2% across the middle 80 percent of the group, with a median of −94.0%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
5 of 319 companies match these filters.Clear filters
| Ticker | Company | Price | 1M return | YTD return | 1Y return |
|---|---|---|---|---|---|
| 0J4V.L | Heron Therapeutics, Inc. | $0.31 | −3.55% | −76.14% | −78.12% |
| 0RK9.L | Alligator Bioscience AB (publ) | 0.03 SEK | +10.16% | −90.40% | −99.13% |
| ATORX.ST | Alligator Bioscience AB (publ) | 0.03 SEK | −32.46% | −91.74% | −99.27% |
| 0HS8.L | Lisata Therapeutics, Inc. | $1.84 | +5.14% | −2.13% | −26.55% |
| 0K2H.L | Moleculin Biotech, Inc. | $0.60 | +0.45% | −81.86% | −94.03% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.